Severe anemia following combined α-interferon/ribavirin therapy of chronic hepatitis C
- 31 December 1998
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (6) , 1033-1034
- https://doi.org/10.1016/s0168-8278(98)80138-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Immune pathophysiology of acquired aplastic anaemiaEuropean Journal of Haematology, 1996
- A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferonJournal of Hepatology, 1996
- Ribavirin as Therapy for Chronic Hepatitis CAnnals of Internal Medicine, 1995
- Molecular Mechanisms of Action of RibavirinClinical Infectious Diseases, 1990
- The possible involvement of interferons in acquired pure red cell aplasiaAmerican Journal of Hematology, 1988